The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
Abstract
Lipoprotein(a) [Lp(a)] is a well-recognized, independent risk factor for atherosclerotic cardiovascular disease, with elevated levels estimated to be prevalent in 20% of the population. Observational and genetic evidence strongly support a causal relationship between high plasma concentrations of Lp(a) and increased risk of atherosclerotic cardiovascular disease-related events, such as myocardial infarction and stroke, and valvular aortic stenosis. In this scientific statement, we review an array of evidence-based considerations for testing of Lp(a) in clinical practice and the utilization of Lp(a) levels to inform treatment strategies in primary and secondary prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Self-citationEvolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., Harrington, R. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801174 · Cited by 3,634
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.003 · Cited by 2,691
Self-citationADOLESCENTS, E. P. O. I. G. F. C. H. A. R. R. I. C. A. (2011) · Pediatrics · doi:10.1542/peds.2009-2107c · Cited by 2,585
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807
Self-citation(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
Effects of extended-release niacin with laropiprant in high-risk patients
The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Kamstrup, P. R. (2009) · JAMA · doi:10.1001/jama.2009.801 · Cited by 1,357
Anderson, T. J., Grégoire, J., Pearson, G. J., Barry, A. R., Couture, P., Dawes, M., Francis, G. A., Genest, J., Grover, S., Gupta, M., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.510 · Cited by 1,173
A Test in Context: Lipoprotein(a)
Tsimikas, S. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.042 · Cited by 1,137
Genetic Associations with Valvular Calcification and Aortic Stenosis
Thanassoulis, G., Campbell, C. Y., Owens, D. S., Smith, J. G., Smith, A. V., Peloso, G. M., Kerr, K. F., Pechlivanis, S., Budoff, M. J., Harris, T. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109034 · Cited by 1,008
Self-citationLipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
Self-citationJacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.02.003 · Cited by 773
Self-citationBurgess, S., Ference, B. A., Staley, J. R., Freitag, D. F., Mason, A. M., Nielsen, S. F., Willeit, P., Young, R., Surendran, P., Karthikeyan, S., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.1470 · Cited by 689
Self-citationFamilial lipoprotein disorders in patients with premature coronary artery disease.
Genest, J. J., Martin-Munley, S. S., McNamara, J. R., Ordovas, J. M., Jenner, J., Myers, R. H., Silberman, S. R., Wilson, P. W., Salem, D. N., & Schaefer, E. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2025 · Cited by 596
Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
Kamstrup, P. R., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.038 · Cited by 595
Self-citationNordestgaard, B. G., & Langsted, A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r071233 · Cited by 575
Self-citationWilleit, P., Ridker, P. M., Nestel, P. J., Simes, J., Tonkin, A. M., Pedersen, T. R., Schwartz, G. G., Olsson, A. G., Colhoun, H. M., Kronenberg, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31652-0 · Cited by 564
Kamstrup, P. R., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2008) · Circulation · doi:10.1161/circulationaha.107.715698 · Cited by 558
Self-citationLipoprotein(a): resurrected by genetics
Kronenberg, F., & Utermann, G. (2013) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02592.x · Cited by 521
Tsimikas, S., Fazio, S., Ferdinand, K. C., Ginsberg, H. N., Koschinsky, M. L., Marcovina, S. M., Moriarty, P. M., Rader, D. J., Remaley, A. T., Reyes-Soffer, G., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.014 · Cited by 501
Self-citationWellcome Trust Case Control Consortium, Trégouët, D.-A., Cardiogenics Consortium, König, I. R., Erdmann, J., Munteanu, A., Braund, P. S., Hall, A. S., Großhennig, A., Linsel-Nitschke, P., et al. (2009) · Nature Genetics · doi:10.1038/ng.314 · Cited by 475
Khera, A. V., Everett, B. M., Caulfield, M. P., Hantash, F. M., Wohlgemuth, J., Ridker, P. M., & Mora, S. (2014) · Circulation · doi:10.1161/circulationaha.113.004406 · Cited by 461
Kenet, G., Lütkhoff, L. K., Albisetti, M., Bernard, T., Bonduel, M., Brandao, L., Chabrier, S., Chan, A., deVeber, G., Fiedler, B., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.913673 · Cited by 449
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
Capoulade, R., Chan, K. L., Yeang, C., Mathieu, P., Bossé, Y., Dumesnil, J. G., Tam, J. W., Teo, K. K., Mahmut, A., Yang, X., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.020 · Cited by 417
Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups
Paré, G., Çaku, A., McQueen, M., Anand, S. S., Enas, E., Clarke, R., Boffa, M. B., Koschinsky, M., Wang, X., Yusuf, S., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.034311 · Cited by 382
Self-citationShlipak, M. G. (2000) · JAMA · doi:10.1001/jama.283.14.1845 · Cited by 371
Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)
Raal, F. J., Giugliano, R. P., Sabatine, M. S., Koren, M. J., Langslet, G., Bays, H., Blom, D., Eriksson, M., Dent, R., Wasserman, S. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.006 · Cited by 361
Marcovina, S. M., Albers, J. J., Gabel, B., Koschinsky, M. L., & Gaur, V. P. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.2.246 · Cited by 354
Self-citationNowak-Göttl, U., Sträter, R., Heinecke, A., Junker, R., Koch, H.-G., Schuierer, G., & von Eckardstein, A. (1999) · Blood · doi:10.1182/blood.v94.11.3678 · Cited by 344
Zheng, K. H., Tsimikas, S., Pawade, T., Kroon, J., Jenkins, W. S. A., Doris, M. K., White, A. C., Timmers, N. K. L. M., Hjortnaes, J., Rogers, M. A., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.070 · Cited by 343
Self-citationPérez de Isla, L., Alonso, R., Mata, N., Fernández-Pérez, C., Muñiz, O., Díaz-Díaz, J. L., Saltijeral, A., Fuentes-Jiménez, F., de Andrés, R., Zambón, D., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024541 · Cited by 342
Lipoprotein (a) measurements for clinical application
Marcovina, S. M., & Albers, J. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r061648 · Cited by 338
Apolipoprotein(a) Isoforms and the Risk of Vascular Disease
Erqou, S., Thompson, A., Di Angelantonio, E., Saleheen, D., Kaptoge, S., Marcovina, S., & Danesh, J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.080 · Cited by 332
Virani, S. S., Brautbar, A., Davis, B. C., Nambi, V., Hoogeveen, R. C., Sharrett, A. R., Coresh, J., Mosley, T. H., Morrisett, J. D., Catellier, D. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.045120 · Cited by 324
Relationship of Apolipoproteins A-1 and B, and Lipoprotein(a) to Cardiovascular Outcomes
Albers, J. J., Slee, A., O'Brien, K. D., Robinson, J. G., Kashyap, M. L., Kwiterovich, P. O., Xu, P., & Marcovina, S. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.051 · Cited by 318
Arsenault, B. J., Boekholdt, S. M., Dubé, M.-P., Rhéaume, É., Wareham, N. J., Khaw, K.-T., Sandhu, M. S., & Tardif, J.-C. (2014) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000400 · Cited by 315
Marcovina, S. M., Albers, J. J., Scanu, A. M., Kennedy, H., Giaculli, F., Berg, K., Couderc, R., Dati, F., Rifai, N., Sakurabayashi, I., et al. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.1956 · Cited by 313
Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
Boffa, M. B., & Koschinsky, M. L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r060582 · Cited by 309
Self-citationGenetic epidemiology and public health: hope, hype, and future prospects
Smith, G. D., Ebrahim, S., Lewis, S., Hansell, A. L., Palmer, L. J., & Burton, P. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67601-5 · Cited by 300
F. T. G. O. C. I., Jaeger, B. R., Richter, Y., Nagel, D., Heigl, F., Vogt, A., Roeseler, E., Parhofer, K., Ramlow, W., Koch, M., et al. (2009) · Nature Reviews Cardiology · doi:10.1038/ncpcardio1456 · Cited by 294
Halperin, J. L., Levine, G. N., Al-Khatib, S. M., Birtcher, K. K., Bozkurt, B., Brindis, R. G., Cigarroa, J. E., Curtis, L. H., Fleisher, L. A., Gentile, F., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000312 · Cited by 291
Marcovina, S. M., Koschinsky, M. L., Albers, J. J., & Skarlatos, S. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.023689 · Cited by 288
Self-citationHigh lipoprotein(a) and high risk of mortality
Langsted, A., Kamstrup, P. R., & Nordestgaard, B. G. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy902 · Cited by 288
Self-citationDiscrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
Willeit, P., Kiechl, S., Kronenberg, F., Witztum, J. L., Santer, P., Mayr, M., Xu, Q., Mayr, A., Willeit, J., & Tsimikas, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.061 · Cited by 286
Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease
Boffa, M. B., & Koschinsky, M. L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0153-2 · Cited by 284
Self-citationLangsted, A., Kamstrup, P. R., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30042-0 · Cited by 270
Self-citationPostmus, I., Trompet, S., Deshmukh, H. A., Barnes, M. R., Li, X., Warren, H. R., Chasman, D. I., Zhou, K., Arsenault, B. J., Donnelly, L. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6068 · Cited by 267
Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.07.005 · Cited by 262
Self-citationLipoprotein (a): impact by ethnicity and environmental and medical conditions
Enkhmaa, B., Anuurad, E., & Berglund, L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r051904 · Cited by 260
Hoff, H. F., Beck, G. J., Skibinski, C. I., Jürgens, G., O'Neil, J., Kramer, J., & Lytle, B. (1988) · Circulation · doi:10.1161/01.cir.77.6.1238 · Cited by 249
Teaching old dogmas new tricks
Brown, M. S., & Goldstein, J. L. (1987) · Nature · doi:10.1038/330113a0 · Cited by 238
Utermann, G., Hoppichler, F., Dieplinger, H., Seed, M., Thompson, G., & Boerwinkle, E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4171 · Cited by 231
Chasman, D. I., Shiffman, D., Zee, R. Y. L., Louie, J. Z., Luke, M. M., Rowland, C. M., Catanese, J. J., Buring, J. E., Devlin, J. J., & Ridker, P. M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.019 · Cited by 228
Roeseler, E., Julius, U., Heigl, F., Spitthoever, R., Heutling, D., Breitenberger, P., Leebmann, J., Lehmacher, W., Kamstrup, P. R., Nordestgaard, B. G., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307983 · Cited by 227
Self-citationLamina, C., Kronenberg, F., & for the Lp(a)-GWAS-Consortium (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1041 · Cited by 218
Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease
O'Donoghue, M. L., Morrow, D. A., Tsimikas, S., Sloan, S., Ren, A. F., Hoffman, E. B., Desai, N. R., Solomon, S. D., Domanski, M., Arai, K., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.042 · Cited by 215
Guan, W., Cao, J., Steffen, B. T., Post, W. S., Stein, J. H., Tattersall, M. C., Kaufman, J. D., McConnell, J. P., Hoefner, D. M., Warnick, R., et al. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304785 · Cited by 215
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies
Craig, W. Y., Neveux, L. M., Palomaki, G. E., Cleveland, M. M., & Haddow, J. E. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.11.2301 · Cited by 210
Kamstrup, P. R., & Nordestgaard, B. G. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.08.006 · Cited by 206
Self-citationLipoprotein (a) as a risk factor for ischemic stroke: A meta-analysis
Nave, A. H., Lange, K. S., Leonards, C. O., Siegerink, B., Doehner, W., Landmesser, U., Steinhagen-Thiessen, E., Endres, M., & Ebinger, M. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.021 · Cited by 200
Kamstrup, P. R., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.248765 · Cited by 194
Self-citationFurther Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System
Halperin, J. L., Levine, G. N., Al-Khatib, S. M., Birtcher, K. K., Bozkurt, B., Brindis, R. G., Cigarroa, J. E., Curtis, L. H., Fleisher, L. A., Gentile, F., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.001 · Cited by 191
Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies
Smolders, B., Lemmens, R., & Thijs, V. (2007) · Stroke · doi:10.1161/strokeaha.106.480657 · Cited by 179
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism
von Depka, M., Nowak-Göttl, U., Eisert, R., Dieterich, C., Barthels, M., Scharrer, I., Ganser, A., & Ehrenforth, S. (2000) · Blood · doi:10.1182/blood.v96.10.3364 · Cited by 174
Sahebkar, A., Reiner, Ž., Simental‐Mendía, L. E., Ferretti, G., & Cicero, A. F. G. (2016) · Metabolism · doi:10.1016/j.metabol.2016.08.007 · Cited by 157
Benn, M., & Nordestgaard, B. G. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy045 · Cited by 155
Self-citationVerbeek, R., Hoogeveen, R. M., Langsted, A., Stiekema, L. C. A., Verweij, S. L., Hovingh, G. K., Wareham, N. J., Khaw, K., Boekholdt, S. M., Nordestgaard, B. G., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy334 · Cited by 155
Self-citationCantin, B., Gagnon, F., Moorjani, S., Després, J., Lamarche, B., Lupien, P. J., & Dagenais, G. R. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00528-7 · Cited by 152
Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia
Ellis, K. L., de Isla, L. P., Rodrigo Alonso, K., Fuentes, F. J., Watts, G. F., & Mata, P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.037 · Cited by 152
Nestel, P. J., Barnes, E. H., Tonkin, A. M., Simes, J. R., Fournier, M., White, H. D., Colquhoun, D. M., Blankenberg, S., & SULLIVAN, D. R. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302479 · Cited by 142
Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)
Gaudet, D., Watts, G. F., Robinson, J. G., Minini, P., Sasiela, W. J., Edelberg, J. M., Louie, M. J., & Raal, F. J. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.09.010 · Cited by 139
Deshmukh, H., Colhoun, H. M., Johnson, T., McKeigue, P., Betteridge, D. J., Durrington, P. N., Fuller, J., Livingstone, S. J., Charlton-Menys, V., Neil, A., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p021113 · Cited by 133
Genome-wide analysis yields new loci associating with aortic valve stenosis
Helgadottir, A., Thorleifsson, G., Gretarsdottir, S., Stefansson, O. A., Tragante, V., Thorolfsdottir, R. B., Jonsdottir, I., Bjornsson, T., Steinthorsdottir, V., Verweij, N., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03252-6 · Cited by 125
Vongpromek, R., Bos, S., ten Kate, G. R., Yahya, R., Verhoeven, A. J. M., de Feyter, P. J., Kronenberg, F., van Lennep, J. E. R., Sijbrands, E. J. G., & Mulder, M. T. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12335 · Cited by 115
Lipoprotein(a), Hormone Replacement Therapy, and Risk of Future Cardiovascular Events
Danik, J. S., Rifai, N., Buring, J. E., & Ridker, P. M. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.009 · Cited by 112
Khan, T. Z., Hsu, L., Arai, A. E., Rhodes, S., Pottle, A., Wage, R., BANYA, W. A. S., Gatehouse, P. D., Giri, S., Collins, P. D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx178 · Cited by 105
Lipoprotein(a) and Cardiovascular Risk Prediction Among Women
Cook, N. R., Mora, S., & Ridker, P. M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.060 · Cited by 104
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study
Parish, S., Hopewell, J. C., Hill, M. R., Marcovina, S., Valdes-Marquez, E., Haynes, R., Offer, A., Pedersen, T. R., Baigent, C., Collins, R., et al. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.117.001696 · Cited by 93
Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis
Yeang, C., Wilkinson, M. J., & Tsimikas, S. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000300 · Cited by 93
LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins
Wei, W., Li, X., Feng, Q., Kubo, M., Kullo, I. J., Peissig, P. L., Karlson, E. W., Jarvik, G. P., Lee, M. T. M., Shang, N., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.031356 · Cited by 93
Pontone, G., Andreini, D., Guglielmo, M., Rota, C., Mushtaq, S., Baggiano, A., Beltrama, V., Solbiati, A., Guaricci, A. I., & Pepi, M. (2016) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(16)31573-x · Cited by 85
Kamstrup, P. R., Hung, M., Witztum, J. L., Tsimikas, S., & Nordestgaard, B. G. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308761 · Cited by 85
Self-citationRosada, A., Kassner, U., Vogt, A., Willhauck, M. J., Parhofer, K. G., & Steinhagen‐Thiessen, E. (2013) · Artificial Organs · doi:10.1111/aor.12135 · Cited by 83
Safety Profile of Extended-Release Niacin in the AIM-HIGH Trial
Anderson, T. J., Boden, W. E., Desvigne-Nickens, P. M., Fleg, J. L., Kashyap, M. L., McBride, R., & Probstfield, J. L. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1311039 · Cited by 82
Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia
Arai, K., Orsoni, A., Mallat, Z., Tedgui, A., Witztum, J. L., Bruckert, É., Tselepis, A. D., Chapman, M. J., & Tsimikas, S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p027235 · Cited by 69
Chen, H. Y., Dufresne, L., Burr, H., Ambikkumar, A., Yasui, N., Luk, K., Ranatunga, D. K., Whitmer, R. A., Lathrop, M. G., Engert, J. C., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.4266 · Cited by 69
High levels of lipoprotein (a) and premature acute coronary syndrome
Rallidis, L. S., Pavlakis, G., Foscolou, A., Kotakos, C., Κατσιμάρδος, Α., Drosatos, A., Zolindaki, M., & Panagiotakos, D. B. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.12.011 · Cited by 69
Steffen, B. T., Duprez, D. A., Bertoni, A. G., Guan, W., & Tsai, M. Y. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311220 · Cited by 69
Lipoprotein(a)-cholesterol: A significant component of serum cholesterol
Kinpara, K., Okada, H., Yoneyama, A., Okubo, M., & Murase, T. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.05.036 · Cited by 67
Goldenberg, N. A., Bernard, T. J., Hillhouse, J., Armstrong, J., Galinkin, J. L., Knapp-Clevenger, R., Jacobson, L. J., Marcovina, S. M., & Manco‐Johnson, M. J. (2013) · Haematologica · doi:10.3324/haematol.2012.073833 · Cited by 66
Review of Lipid and Lipoprotein(a) Abnormalities in Childhood Arterial Ischemic Stroke
Sultan, S. M., Schupf, N., Dowling, M. M., deVeber, G., Kirton, A., & Elkind, M. S. V. (2013) · International Journal of Stroke · doi:10.1111/ijs.12136 · Cited by 62
Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: Insights from the Fourier trial
O’Donoghue, M. L., Giugliano, R. P., KEECH, A. C., Kanevsky, E., Im, K., Pineda, A. L., Somaratne, R. M., Sever, P. S., Pederson, T. S., & Sabatine, M. S. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.912 · Cited by 61
Ellis, K. L., Pang, J., Chan, D. C., Hooper, A. J., Bell, D. A., Burnett, J. R., & Watts, G. F. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.08.011 · Cited by 58
Kotani, K., Șerban, M.-C., Penson, P. E., Lippi, G., & Banach, M. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2016.1188055 · Cited by 51
Suwa, S., Ogita, M., Miyauchi, K., Sonoda, T., Konishi, H., Tsuboi, S., Wada, H., Naito, R., Dohi, T., Kasai, T., et al. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.38794 · Cited by 47
The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on
Scientific Board of GLAR for the German Apheresis Working Group, Schettler, V. J. J., Neumann, C. L., Peter, C., Zimmermann, T. P., Julius, U., Roeseler, E., Heigl, F., Grützmacher, P., Blume, H., et al. (2017) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-017-0089-9 · Cited by 46
Langsted, A., Kamstrup, P. R., & Nordestgaard, B. G. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.276931 · Cited by 42
Self-citationMin, W., Lee, J. O., & Huh, J. W. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.10.1891 · Cited by 38
Zawacki, A. W., Dodge, A., Woo, K. M., Ralphe, J. C., & Peterson, A. L. H. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.07.014 · Cited by 38
Moriarty, P. M., & Hemphill, L. (2015) · Cardiology Clinics · doi:10.1016/j.ccl.2015.02.002 · Cited by 34
Lipoprotein (a): Examination of Cardiovascular Risk in a Pediatric Referral Population
Qayum, O., Alshami, N., Ibezim, C. F., Reid, K. J., Noel‐MacDonnell, J., & Raghuveer, G. (2018) · Pediatric Cardiology · doi:10.1007/s00246-018-1927-3 · Cited by 32
Dyslipidemia in Children With Arterial Ischemic Stroke: Prevalence and Risk Factors
Sultan, S. M., Dowling, M. M., Kirton, A., deVeber, G., Linds, A. B., Elkind, M. S. V., Bernard, T., Dowling, M. M., Hernández, M., Rivkin, M. J., et al. (2017) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.09.019 · Cited by 30
Inverse association between serum lipoprotein(a) and cerebral hemorrhage in the Japanese population
Ishikawa, S., Kotani, K., Kario, K., Kayaba, K., Gotoh, T., Nakamura, Y., & Kajii, E. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.11.032 · Cited by 27
High Lipoprotein(a) Concentrations Are Associated with Impaired Endothelial Function in Children
Lapinleimu, J., Raitakari, O. T., Lapinleimu, H., Pahkala, K., Rönnemaa, T., Simell, O., & Viikari, J. S. A. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.12.051 · Cited by 27
HIV and coronary arterial remodeling from the Multicenter AIDS Cohort Study (MACS)
Miller, P. E., Haberlen, S., Metkus, T. S., Rezaeian, P., Palella, F. J., Kingsley, L., Witt, M. D., George, R. T., Jacobson, L. P., Brown, T. T., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.022 · Cited by 26
Vuorio, A. F., Watts, G. F., & Kovanen, P. T. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx546 · Cited by 24
JCL roundtable—Lipoprotein(a): The emerging risk factor
Marcovina, S. M., Moriarty, P. M., Koschinsky, M. L., & Guyton, J. R. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.11.003 · Cited by 14
Self-citation
Cited by
Kronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M., Lambert, G., Mach, F., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac361 · Cited by 1,449
Self-citationReyes-Soffer, G., Ginsberg, H. N., Berglund, L., Duell, P. B., Heffron, S. P., Kamstrup, P. R., Lloyd-Jones, D. M., Marcovina, S. M., Yeang, C., Koschinsky, M. L., et al. (2022) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000147 · Cited by 836
Self-citationSmall Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
O’Donoghue, M. L., Rosenson, R. S., Gencer, B., López, J. A. G., Lepor, N. E., Baum, S. J., Stout, E., Gaudet, D., Knusel, B., Kuder, J. F., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2211023 · Cited by 599
Patel, A. P., Wang, M., Pirruccello, J. P., Ellinor, P. T., Ng, K., Kathiresan, S., & Khera, A. V. (2021) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.120.315291 · Cited by 567
A Modern Approach to Dyslipidemia
Berberich, A. J., & Hegele, R. A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab037 · Cited by 469
Metadata
- Authors
- Wilson, D. P., Jacobson, T. A., Jones, P. H., Koschinsky, M. L., McNeal, C. J., Nordestgaard, B. G., & Orringer, C. E.
- Venue
- Journal of Clinical Lipidology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 13
- Issue
- 3
- Pages
- 374-392
- ISSN
- 1876-4789 (ISSN-L)
- 1933-2874
- OpenAlex
- W2945006463
- Cited by
- 518
- References
- 118
- FWCI
- 49.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.